112 related articles for article (PubMed ID: 12648606)
1. Immunohistochemical determination of hormone receptors in uterine adenosarcomas.
Amant F; Gabriel C; Moerman P; Vergote I
Gynecol Oncol; 2003 Mar; 88(3):463-4. PubMed ID: 12648606
[No Abstract] [Full Text] [Related]
2. Ovarian conservation and hormone receptors in uterine Müllerian adenosarcomas.
Tjalma WA
Gynecol Oncol; 2003 Dec; 91(3):659; author reply 660-1. PubMed ID: 14675697
[No Abstract] [Full Text] [Related]
3. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
[TBL] [Abstract][Full Text] [Related]
5. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
[TBL] [Abstract][Full Text] [Related]
6. Correspondence re: Mikami Y, Hata S, Kiyokawa T, Manabe T. Expression of CD10 in malignant mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod pathol 2002;15:923-30.
Zamecnik M
Mod Pathol; 2003 Jun; 16(6):618-9; author reply 619. PubMed ID: 12808069
[No Abstract] [Full Text] [Related]
7. Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas.
Marcus JZ; Klobocista M; Karabakhtsian RG; Prossnitz E; Goldberg GL; Huang GS
Int J Gynecol Cancer; 2018 Mar; 28(3):500-504. PubMed ID: 29303935
[TBL] [Abstract][Full Text] [Related]
8. CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
Van Mieghem T; Abeler VM; Moerman P; Verbist L; Vergote I; Amant F
Gynecol Oncol; 2005 Nov; 99(2):493-6. PubMed ID: 16051333
[TBL] [Abstract][Full Text] [Related]
9. Uterine Adenosarcoma.
Pinto A; Howitt B
Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
[TBL] [Abstract][Full Text] [Related]
10. Adenosarcoma of the uterine corpus associated with ovarian thecoma.
Nomura K; Aizawa S; Ushigome S
Pathol Int; 2001 Sep; 51(9):735-8. PubMed ID: 11696179
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
[TBL] [Abstract][Full Text] [Related]
12. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
Gallardo A; Prat J
Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
[TBL] [Abstract][Full Text] [Related]
13. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
[TBL] [Abstract][Full Text] [Related]
14. [Local uterine hormonemia and steroid hormone receptors].
Savitskiĭ GA; Savchenko ON; Sekretareva EV; Usova AA; Svechnikova FA
Akush Ginekol (Mosk); 1985 Feb; (2):19-22. PubMed ID: 3158222
[No Abstract] [Full Text] [Related]
15. [Steroid hormone receptors in normal uterine endometrium and uterine adenocarcinoma of human subjects (author's transl)].
Nioka S
Nihon Naibunpi Gakkai Zasshi; 1978 Feb; 54(2):158-73. PubMed ID: 640096
[No Abstract] [Full Text] [Related]
16. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptors in vaginal and uterine adenocarcinomas following estrogen use.
Eisenfeld AJ; Schwartz PE; Morris JM
Gynecol Oncol; 1980 Aug; 10(1):63-8. PubMed ID: 7399330
[No Abstract] [Full Text] [Related]
18. Pathology of mixed Müllerian tumours.
D'Angelo E; Prat J
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
[TBL] [Abstract][Full Text] [Related]
19. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas.
Sun X; Mittal K
Int J Gynecol Pathol; 2010 Jan; 29(1):51-4. PubMed ID: 19952937
[TBL] [Abstract][Full Text] [Related]
20. [A comparative analysis of progesterone and estradiol reception in human myoma].
Sergeev PV; Karpeva EN; Tkacheva NIu
Biull Eksp Biol Med; 1994 Jul; 118(7):33-4. PubMed ID: 7919269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
